Ly6Chigh

Ly6Chigh refers to a subset of mouse monocytes characterized by high surface expression of Ly6C, a marker used to distinguish inflammatory monocytes from other circulating myeloid cells. In mouse immunology, circulating monocytes are commonly divided into Ly6C high (Ly6C^hi) and Ly6C low (Ly6C^lo) populations, often in combination with markers such as CD11b and CD115 (CSF-1R). Ly6C is not a standard marker used for human monocytes, where classical and non-classical subsets are typically defined by CD14 and CD16 expression.

Ly6C^hi monocytes originate in the bone marrow and are mobilized into the bloodstream in response to inflammatory cues. They express CCR2 and are preferentially recruited to sites of tissue injury or infection via CCL2–CCR2 signaling. Upon reaching tissues, Ly6C^hi cells can differentiate into inflammatory macrophages or dendritic cells, including TNF- and iNOS-producing dendritic cells in certain contexts. They also actively produce pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, contributing to early defense as well as collateral tissue damage depending on the milieu.

Function and relevance in disease vary by context. In acute inflammation, Ly6C^hi monocytes are key to rapid pathogen clearance and recruitment of other immune cells. In chronic diseases, they can influence progression through sustained recruitment and differentiation into macrophage-like or dendritic cell populations, affecting tissue remodeling, atherosclerosis, and tumor-associated inflammation. Their behavior is often studied using CCR2-dependent recruitment models and fate-mapping approaches in mice.

In humans, analogous concepts exist but without Ly6C as a marker. Human inflammatory monocytes are typically described as CD14++ CD16− (classical) or CD14+ CD16++ (non-classical), with functional parallels to the Ly6C^hi and Ly6C^lo subsets observed in mice.

---